Like many other companies and institutions around the world, we are experiencing interference with some of our systems within the TNT network.
We are implementing remediation steps as quickly as possible. We have implemented operational contingencies to continue to complete collections from customers with scheduled stops. For customers who do not have a regular stop, collection should be arranged via our customer service centers.
Customers may experience delays in the transit of shipments, particularly inter-continental or non-EU European delivery, as we work to remediate our systems. Additionally, if customers do not have the facility for self-labeling, they may also experience delays.
We are not able to collect shipments of dangerous goods at this time.
We regret any inconvenience to our customers.
Method Development and Validation
Developing and Validating 180 Drug Substances and Drug Product Methods Each Year
Our analytical team has a proven track record in rapid method transfer, method development and method validation.
Working closely with our clients, we deliver robust, efficient, stability-indicating and fit-for-purpose analytical methods. We fully understand and comply with the analytical support demanded by regulatory authorities at each stage of the drug product lifecycle.
Our unique blend of experience, expertise, and focus enables us to deliver, reliable, information-rich methods to meet your exact requirements. Typical analytical techniques include, but are not limited to:
- HPLC and U(H)PLC
- Ion Chromotography
- Dissolution (USP apparatus 1 and 2)
- LC-MS / GC-MS
- Particle size by laser diffraction
- Volumetric/ Coulometric KF
- Potentiometric Titration
- UV Spectrophotometry
- Fluoresence Spectrophotometry
Utilising the extensive library of in-house methods, statistical exploration tools, and emerging analytical technologies, such as UPLC™ and Empower 2, we can reduce your method development, validation time and associated costs while generating accurate and reliable data.